MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Interest

Name: MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

MEDICAL DEVELOPMENTS ORDINARY (ASX:MVP) had 0.01% of shares reported as short positions as of 16 May 2026, representing 6,324 shares. MEDICAL DEVELOPMENTS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest: 0.01%
Reported positions: 6,324
Industry: Pharmaceuticals, Biotechnology & Life Sciences
As of: 16 May 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

MVP

Medical Developments International

Pharmaceuticals, Biotechnology & Life Sciences

Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.

pharmaceuticals

biotechnology

medical devices

pain management

Shorted

short percentage0.01%

reported shorts6.3K

shares on issue112.658M